Back to search

University of Thessaly (UTH)

Μελέτη πρωτεϊνών επαγουσών την κυτταρική επιβίωση σε μυελοδυσπλαστικά σύνδρομα

Abstract

dc:description

Aim: The aim of this study is to investigate factors that are involved in the survival and expansion of neoplastic clone in myelodysplastic syndromes although they are characterized by increased apoptosis of hemopoietic cells. This survival process leads to accumulation of immature cells (blasts) and disease progression to acute leukaemia. Introduction: In early stages of the disease the neoplastic clone do not present surviving advantages over the normal hemopoietic cells. The expansion of the MDS clone is achieved after an immune insult of the normal bone marrow. During disease progress mutations are accumulated that produce survival advantage and maturation arrest to the neoplastic clone. Survivin is an apoptosis inhibitor not expressed in normal cells but found expressed in neoplastic cells in various tumours and has been associated to cell proliferation and survival. Materials and Methods: One hundred and forty-two patients (87 males and 55 females) with median age 72 years as well as 53 healthy controls (22 males and 35 females) with median age 74 years were involved in the study. The expression of survivin was studied in the CD34+ cells of the bone marrow using real-time pcr. Mutation analysis was done to the survivin cDNA using Sanger’s method for direct sequencing. The levels of survivin in cell eluate from bone marrow CD34+ cell cultures were measured using ELISA(Cell Signalling Tecnology,Geneway Biotech, R&D). In addition the expression of genes involved in the apoptosis pathway and NFk-B pathway using commercially available cDNA microarrays(Taqman®).Results: We found that the survivin levels in the cell eluate from cell cultures of isolated CD34+ bone marrow cells from patients with high/intermediate-2 risk MDS had mean(±SD) value 536.37±159.208pg/ml while in the low/intermediate-1risk MDS the corresponding value was 177.58±58.87 pg/ml. In the control group the survivin levels were not detectable. The levels of survivin in the high/intermediate-2 group were statistically significantly higher than those in the low/intermediate-1 group (p<0.001).The expression of survivin (number of transcripts) was higher in MDS of high/intermediate-2 group than in MDS of low/intermediate-1 group (p<0.001). The expression of survivin in low/intermediate-1 was significantly higher than in the normal controls(p<0.001). Mutations were not detected in survivin gene with direct sequencing.No statistically significant difference was detected in the expression of the various genes of the microarray of the NFk-B pathway used among the various studied groups(p=0.2)The genes AIFM1, AKT1, APAF1, ATM,BAD, BBC3, BID, CASP3, CASP7, CASP8, CASP9, CYCS, DAPK3, DAXX,DFFA, DFFB, P53AIP1 that induce apoptosis were found overexpressed in the low/intermediate-1 group compared to the high/intermediate-2 group and normal controls(p<0.001)Conclusions: Survivin is overexpressed in MDS cells although these cells present increased apoptosis compared to the normal cells. Taking in account that survivin induces cell proliferation and inhibits apoptosis it is suggested that other possible factors influence the balance between survival or death in the difference stages of the disease evolution.

Degree

thesis:*
Grantor dc:publisher
University of Thessaly (UTH)
Year dc:date
2018

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Kourelis, Taxiarchis
  • Κουρέλης, Ταξιάρχης

Subjects

dc:subject × 12

Rights

dc:rights
Statement dc:rights
  • BY
Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/43510

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Kourelis, Taxiarchis; Κουρέλης, Ταξιάρχης. Μελέτη πρωτεϊνών επαγουσών την κυτταρική επιβίωση σε μυελοδυσπλαστικά σύνδρομα. University of Thessaly (UTH), 2018. http://hdl.handle.net/10442/hedi/43510